4-Methyl-N-(5-methylpyridin-2-yl)benzamide

Catalog No. :
ACBHPQ372
CAS No. :
349122-64-1
Molecular Formula :
C14H14N2O
Molecular Weight :
226.28

IUPAC Name:4-methyl-N-(5-methylpyridin-2-yl)benzamide

4-Methyl-N-(5-methylpyridin-2-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$71.00Login to see priceIn stockInquiry
250mg97%$127.00Login to see priceIn stockInquiry
1g97%$345.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-N-(5-methylpyridin-2-yl)benzamide
IUPAC Name4-methyl-N-(5-methylpyridin-2-yl)benzamide
Molecular FormulaC14H14N2O
Molecular Weight226.28
SMILESO=C(NC1=NC=C(C)C=C1)C2=CC=C(C)C=C2
InChI KeyNBFFPKCKCRTTRE-UHFFFAOYSA-N
Synonym4-Methyl-N-(5-Methyl-2-pyridinyl)benzaMide (ZolpideM IMpurity);ZolpideM IMpurity;Zolpyridine;Zolpidem USP RC C;Zolpidem USP Related Compound C;Zolpidem Related Compound C;Zolpidem Impurity 3(Zolpidem USP RC C);Zolpidem tartrate Impurity 4
CAS No.349122-64-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBHPQ372 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBHPQ372 route product structure diagram
    ACBHPQ372349122-64-1 In Stock
Inquiry

2. ACBHPQ372 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBHPQ372 route product structure diagram
    ACBHPQ372349122-64-1 In Stock
Inquiry

Comments (0)